Revenue Breakdown
Composition ()
No data
Revenue Streams
ICU Medical Inc (ICUI) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Consumables, accounting for 53.1% of total sales, equivalent to $285.09M. Other significant revenue streams include Infusion Consumables and Infusion Systems. Understanding this composition is critical for investors evaluating how ICUI navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, ICU Medical Inc maintains a gross margin of 37.41%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 5.00%, while the net margin is -0.63%. These profitability ratios, combined with a Return on Equity (ROE) of -0.35%, provide a clear picture of how effectively ICUI converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, ICUI competes directly with industry leaders such as NVST and LIVN. With a market capitalization of $3.64B, it holds a significant position in the sector. When comparing efficiency, ICUI's gross margin of 37.41% stands against NVST's 55.99% and LIVN's 68.44%. Such benchmarking helps identify whether ICU Medical Inc is trading at a premium or discount relative to its financial performance.
